<DOC>
	<DOCNO>NCT00710866</DOCNO>
	<brief_summary>The purpose study compare antibody response reaction rate child age 6-23 month give either currently recommend schedule two 0.25ml dos influenza vaccine one month apart two 0.5ml dos influenza vaccine , one month apart .</brief_summary>
	<brief_title>Influenza Vaccine Dose-Response Infants Toddlers : Immunogenicity Reactogenicity</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Child healthy ( stable chronic condition acceptable ) establish health assessment interview verbal historydirected health examination Child include 6 month age 23 month age ( include day 24 month age ) Child available complete relevant procedure entire study period Parent legal guardian available reach phone entire study period Parent/guardian provide write informed consent Parent/guardian fluent English Child history laboratoryconfirmed influenza Child history prior influenza immunization Child history anaphylactic reaction component vaccine ( i.e . egg ) Child receive immune globulin blood product within prior six week Child receive injected oral steroid within prior six week ( inhaled topical steroid allow ) Child bleed diathesis condition associate prolonged bleeding time would contraindicate intramuscular injection ( thrombocytopenia , coagulation disorder , anticoagulant therapy ) Child enrol clinical trial drug , vaccine medical device study period Child schedule receive live vaccine ( notably measles , mumps , rubella varicella vaccine ) study period Child health condition , opinion investigator , would interfere evaluation pose health risk child</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Influenza Vaccines</keyword>
	<keyword>Infant</keyword>
	<keyword>Dose-Response Relationship , Immunologic</keyword>
</DOC>